BACKGROUND: Swine outbreaks of pandemic influenza A (pH1N1) suggest human introduction of the virus into herds. This study investigates a pH1N1 outbreak occurring on a swine research farm with 37 humans and 1300 swine in Alberta, Canada, from 12 June through 4 July 2009. METHODS: The staff was surveyed about symptoms, vaccinations, and livestock exposures. Clinical findings were recorded, and viral testing and molecular characterization of isolates from humans and swine were performed. Human serological testing and performance of the human influenza-like illness (ILI) case definition were also studied. RESULTS: Humans were infected before swine. Seven of 37 humans developed ILI, and 2 (including the index case) were positive for pH1N1 by reverse-transcriptase polymerase chain reaction (RT-PCR). Swine were positive for pH1N1 by RT-PCR 6 days after contact with the human index case and developed symptoms within 24 h of their positive viral test results. Molecular characterization of the entire viral genomes from both species showed minor nucleotide heterogeneity, with 1 amino acid change each in the hemagglutinin and nucleoprotein genes. Sixty-seven percent of humans with positive serological test results and 94% of swine with positive swab specimens had few or no symptoms. Compared with serological testing, the human ILI case definition had a specificity of 100% and sensitivity of 33.3%. The only factor associated with seropositivity was working in the swine nursery. CONCLUSIONS: Epidemiologic data support human-to-swine transmission, and molecular characterization confirms that virtually identical viruses infected humans and swine in this outbreak. Both species had mild illness and recovered without sequelae.
BACKGROUND:Swine outbreaks of pandemic influenza A (pH1N1) suggest human introduction of the virus into herds. This study investigates a pH1N1 outbreak occurring on a swine research farm with 37 humans and 1300 swine in Alberta, Canada, from 12 June through 4 July 2009. METHODS: The staff was surveyed about symptoms, vaccinations, and livestock exposures. Clinical findings were recorded, and viral testing and molecular characterization of isolates from humans and swine were performed. Human serological testing and performance of the humaninfluenza-like illness (ILI) case definition were also studied. RESULTS:Humans were infected before swine. Seven of 37 humans developed ILI, and 2 (including the index case) were positive for pH1N1 by reverse-transcriptase polymerase chain reaction (RT-PCR). Swine were positive for pH1N1 by RT-PCR 6 days after contact with the human index case and developed symptoms within 24 h of their positive viral test results. Molecular characterization of the entire viral genomes from both species showed minor nucleotide heterogeneity, with 1 amino acid change each in the hemagglutinin and nucleoprotein genes. Sixty-seven percent of humans with positive serological test results and 94% of swine with positive swab specimens had few or no symptoms. Compared with serological testing, the human ILI case definition had a specificity of 100% and sensitivity of 33.3%. The only factor associated with seropositivity was working in the swine nursery. CONCLUSIONS: Epidemiologic data support human-to-swine transmission, and molecular characterization confirms that virtually identical viruses infected humans and swine in this outbreak. Both species had mild illness and recovered without sequelae.
Authors: Krista J Howden; Egan J Brockhoff; Francois D Caya; Laura J McLeod; Martin Lavoie; Joan D Ing; Janet M Bystrom; Soren Alexandersen; John M Pasick; Yohannes Berhane; Margaret E Morrison; Julia M Keenliside; Sonja Laurendeau; Elizabeth B Rohonczy Journal: Can Vet J Date: 2009-11 Impact factor: 1.008
Authors: Elke Lange; Donata Kalthoff; Ulrike Blohm; Jens P Teifke; Angele Breithaupt; Christina Maresch; Elke Starick; Sasan Fereidouni; Bernd Hoffmann; Thomas C Mettenleiter; Martin Beer; Thomas W Vahlenkamp Journal: J Gen Virol Date: 2009-07-10 Impact factor: 3.891
Authors: Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron Journal: Am J Epidemiol Date: 2008-01-29 Impact factor: 4.897
Authors: Kanti Pabbaraju; Sallene Wong; Anita A Wong; Greg D Appleyard; Linda Chui; Xiao-Li Pang; Stephanie K Yanow; Kevin Fonseca; Bonita E Lee; Julie D Fox; Jutta K Preiksaitis Journal: J Clin Microbiol Date: 2009-09-02 Impact factor: 5.948
Authors: Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth Journal: Science Date: 2009-05-11 Impact factor: 47.728
Authors: J Patrick Gorres; Kelly M Lager; Wing-Pui Kong; Michael Royals; John-Paul Todd; Amy L Vincent; Chih-Jen Wei; Crystal L Loving; Eraldo L Zanella; Bruce Janke; Marcus E Kehrli; Gary J Nabel; Srinivas S Rao Journal: Clin Vaccine Immunol Date: 2011-09-14
Authors: Matt Allerson; John Deen; Susan E Detmer; Marie R Gramer; Han Soo Joo; Anna Romagosa; Montserrat Torremorell Journal: Vaccine Date: 2012-11-20 Impact factor: 3.641
Authors: S J Lycett; G Baillie; E Coulter; S Bhatt; P Kellam; J W McCauley; J L N Wood; I H Brown; O G Pybus; A J Leigh Brown Journal: J Gen Virol Date: 2012-09-12 Impact factor: 3.891
Authors: Karen K Wong; Adena Greenbaum; Maria E Moll; James Lando; Erin L Moore; Rahul Ganatra; Matthew Biggerstaff; Eugene Lam; Erica E Smith; Aaron D Storms; Jeffrey R Miller; Virginia Dato; Kumar Nalluswami; Atmaram Nambiar; Sharon A Silvestri; James R Lute; Stephen Ostroff; Kathy Hancock; Alicia Branch; Susan C Trock; Alexander Klimov; Bo Shu; Lynnette Brammer; Scott Epperson; Lyn Finelli; Michael A Jhung Journal: Emerg Infect Dis Date: 2012-12 Impact factor: 6.883